Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H25NO |
| Molecular Weight | 277.4342 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CCCC[C@]13CCN([C@H]2CC4=CC=C(OC([2H])([2H])[2H])C=C34)C([2H])([2H])[2H]
InChI
InChIKey=MKXZASYAUGDDCJ-QNNIAVNKSA-N
InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1/i1D3,2D3
| Molecular Formula | C18H25NO |
| Molecular Weight | 277.4342 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Dextromethorphan D6 is a weak uncompetitive antagonist of the NMDA receptor. Dextromethorphan is also acts at nicotinic receptors, sigma-1 rcptor and serotonin and norepinephrine transporters. The incorporation of deuterium serves to reduce dextromethorphan first-pass liver metabolism. AVP-786 is an oral formulation of a combination of deuterated (d6)-dextromethorphan and an ultra-low dose of quinidine. Avanir Pharmaceuticals launched a phase III development program of AVP-786 for the treatment of agitation in patients with Alzheimer's disease.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:45:14 GMT 2023
by
admin
on
Sat Dec 16 09:45:14 GMT 2023
|
| Record UNII |
427476LZFT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2569466
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
100000176367
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
DE-127
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
C166711
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
10288
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
427476LZFT
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
25052519
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY | |||
|
1079043-55-2
Created by
admin on Sat Dec 16 09:45:14 GMT 2023 , Edited by admin on Sat Dec 16 09:45:14 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
